Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Total Assets Over TimeExpanding
Percentile Rank100
3Y CAGR+11.1%
5Y CAGR+34.2%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+11.1%/yr
vs +43.0%/yr prior
5Y CAGR
+34.2%/yr
Recent deceleration
Acceleration
-31.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$2.53B+22.4%
2024$2.06B+19.1%
2023$1.73B-5.9%
2022$1.84B+66.7%
2021$1.10B+90.4%
2020$579.92M+2.5%
2019$565.87M+28.5%
2018$440.25M-15.3%
2017$519.95M+98.8%
2016$261.51M-